Pfizer vaccine could be ready before Christmas

British government who bought vaccine doses for 20 million people, hopes that a German vaccine backed by Pfizer could be ready to distribute before Christmas, if the drug is shown to be successful, with the first doses reserved for the elderly and most vulnerable. Albert Bourla, CEO of Pfizer said that the vaccine was in the “last mile” and that the pharmaceutical company expected results within the next few weeks.

The other competing Oxford’s vaccine may not provide results until after Christmas. The announcement came amid a study by Imperial College London, after analysing data from swabs of 86, 000 people which showed the second wave of the pandemic in England has now reached a critical stage, as 1.28 per cent of people in England were infected more than double the proportion reported at the start of this month and an accelerating rise in infection.